Stanley R Riddell Selected Research

Stanley R Riddell Research Topics

Disease

88	Neoplasms (Cancer) 04/2024 - 08/2002
20	Leukemia 04/2024 - 03/2002
19	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2022 - 12/2002
14	Infections 01/2024 - 09/2002
11	Lymphoma (Lymphomas) 06/2023 - 09/2008
8	Hematologic Neoplasms (Hematological Malignancy) 04/2024 - 01/2004
6	Melanoma (Melanoma, Malignant) 01/2023 - 05/2005
6	Multiple Myeloma 01/2023 - 07/2011
5	Cytokine Release Syndrome 10/2023 - 11/2017
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2023 - 11/2010
4	Testicular Neoplasms (Testicular Cancer) 12/2020 - 07/2011
3	B-Cell Lymphoma (Lymphoma, B Cell) 10/2023 - 01/2007
3	Sarcoma (Soft Tissue Sarcoma) 10/2023 - 09/2017
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2022 - 06/2010
3	Lymphopenia (Lymphocytopenia) 01/2022 - 01/2003
3	Virus Diseases (Viral Diseases) 01/2022 - 01/2007
3	Synovial Sarcoma (Synovioma) 01/2021 - 01/2019
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2019 - 08/2013
3	Inflammation (Inflammations) 01/2019 - 09/2002
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 01/2016
2	Measles 01/2022 - 11/2019
2	Neutropenia 01/2022 - 08/2013
2	Disease Progression 01/2021 - 09/2017
2	Myxoid Liposarcoma 01/2021 - 01/2019
2	Breast Neoplasms (Breast Cancer) 01/2021 - 07/2006
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2010 - 09/2008
2	Renal Cell Carcinoma (Grawitz Tumor) 08/2008 - 12/2004
1	Neoplasm Metastasis (Metastasis) 01/2024
1	Glioblastoma (Glioblastoma Multiforme) 10/2022
1	Chronic Disease (Chronic Diseases) 10/2022
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2021

Drug/Important Bio-Agent (IBA)

46	Chimeric Antigen ReceptorsIBA 04/2024 - 09/2008
43	AntigensIBA 02/2024 - 03/2002
13	Minor Histocompatibility AntigensIBA 03/2011 - 08/2002
11	CytokinesIBA 02/2024 - 04/2009
10	Neoplasm Antigens (Tumor Antigens)IBA 01/2023 - 05/2005
7	CD19-specific chimeric antigen receptorIBA 11/2019 - 01/2016
6	Immune Checkpoint InhibitorsIBA 11/2022 - 01/2018
5	Proteins (Proteins, Gene)FDA Link 01/2024 - 08/2004
5	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2023 - 11/2019
5	LigandsIBA 10/2022 - 04/2003
5	EpitopesIBA 01/2022 - 07/2006
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2016
5	Peptides (Polypeptides)IBA 07/2011 - 05/2005
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2024 - 01/2014
4	Interleukin-2 (IL2)IBA 01/2023 - 09/2003
4	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2023 - 11/2019
4	fludarabineIBA 11/2017 - 12/2004
4	HLA Antigens (Human Leukocyte Antigens)IBA 04/2015 - 05/2003
3	RNA (Ribonucleic Acid)IBA 04/2024 - 10/2008
3	H antigenIBA 04/2024 - 08/2002
3	Monoclonal AntibodiesIBA 01/2024 - 11/2010
3	Interleukin-15 (Interleukin 15)IBA 01/2023 - 01/2021
3	B-Cell Maturation AntigenIBA 01/2023 - 11/2019
3	AntibodiesIBA 11/2022 - 06/2017
3	Immunoglobulin G (IgG)IBA 01/2022 - 11/2016
3	AutoantigensIBA 12/2020 - 08/2007
3	micaIBA 04/2009 - 04/2003
2	Biomarkers (Surrogate Marker)IBA 11/2022 - 11/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 12/2015
2	InterferonsIBA 12/2020 - 01/2019
2	ibrutinibIBA 01/2020 - 09/2017
2	Epithelial Cell Adhesion MoleculeIBA 12/2019 - 01/2019
2	Cetuximab (Erbitux)FDA Link 11/2016 - 08/2011
2	Ganciclovir (Cytovene)FDA LinkGeneric 08/2013 - 10/2003
2	Receptor Tyrosine Kinase-like Orphan ReceptorsIBA 06/2013 - 11/2010
2	MHC class I-related chain AIBA 04/2009 - 04/2003
2	NK Cell Lectin-Like Receptor Subfamily KIBA 04/2009 - 04/2003
2	Thymidine KinaseIBA 03/2006 - 02/2003
2	DNA (Deoxyribonucleic Acid)IBA 04/2005 - 01/2003
1	Single-Chain AntibodiesIBA 02/2024
1	human ERBB2 proteinIBA 02/2024
1	Transaminases (Aminotransferases)IBA 01/2024
1	durvalumabIBA 10/2023
1	Toll-Like Receptor 4IBA 10/2023
1	NKTR-255IBA 01/2023
1	crenigacestatIBA 01/2023
1	SolutionsIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 11/2022
1	Cell Surface ReceptorsIBA 10/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	Antigen Receptors (Antigen Receptor)IBA 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	ChemokinesIBA 01/2021
1	bempegaldesleukinIBA 12/2020

Therapy/Procedure

51	Therapeutics 04/2024 - 03/2002
26	Immunotherapy 04/2024 - 03/2002
13	Cell Transplantation 10/2022 - 12/2004
12	Drug Therapy (Chemotherapy) 10/2022 - 11/2009
10	Hematopoietic Stem Cell Transplantation 04/2024 - 03/2002
4	Transplantation 04/2013 - 01/2003
4	Stem Cell Transplantation 07/2011 - 01/2003
2	Radiotherapy 10/2023 - 12/2009
1	Immunomodulation 10/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022
1	Aftercare (After-Treatment) 12/2020